1Director of Public Health Network, Dammam, Saudi Arabia
2King Abdulaziz Specilaist Hospital, Taif, Saudi Arabia
3King Abdulaziz Hospital, Jeddah, Saudi Arabia
4Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia
5King Salman Bin Abdulaziz Medical City, Madinah, Saudi Arabia
6King Fahad Hospital, Madinah, Saudi Arabia
7Khulais General Hospital, Khulais, Saudi Arabia
8Shaqra University, Riyadh, Saudi Arabia
9King Fahad Central Hospital, Jazan, Saudi Arabia
10Lublin Medical University, Poland
11Tabuk University, Tabuk, Saudi Arabia
12King Khalid University, Abha, Saudi Arabia
13Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia
Introduction: Asthma is a diverse chronic clinical illness that causes inflammation and airway constriction and primarily affects the lower respiratory tract and is characterized by wheezing, dyspnea, and coughing that may be episodic or ongoing. It frequently manifests in childhood and is frequently accompanied by ailments like eczema and hay fever. This activity describes the diagnosis, management, and involvement of the interprofessional team in the care of patients with asthma. These signs and the spirometry-based proof of reversible airway blockage are necessary for the diagnosis of asthma. It is helpful to identify allergy sensitivities that are clinically significant. While daily inhaled corticosteroids are the gold standard of therapy for persistent asthma, inhaled short-acting 2-agonists can quickly relieve acute symptoms. For patients for whom inhaled corticosteroids alone are not sufficient, combination therapy with long-acting 2-agonists is useful. Inhaled long-acting 2-agonists should not be used exclusively. Long-acting muscarinic antagonists (such as tiotropium) and biological medicines that target proteins involved in the etiology of asthma are further controller strategies (e.g. omalizumab, mepolizumab, reslizumab).
Aim of the Study: The purpose of the literature review is to understand various investigations, differential diagnoses, and treatments of asthma.
Methodology: The present study is a comprehensive research of PUBMED since the year 2011 to 2022.
Conclusion: Variable airway obstruction, airway hyperresponsiveness, and airway inflammation are hallmarks of asthma. Avoiding aggravating environmental factors, having access to short-acting 2-agonists for quick symptom relief, and using inhaled corticosteroids on a daily basis are all necessary for the management of chronic asthma. In cases of moderate and severe asthma, additional controller drugs, such as long-acting bronchodilators and biologics, can be needed. In general, patients with severe asthma benefit from speaking with an asthma expert to discuss possible additional treatments, such as injectable biologics.
Keywords: Asthma; Airway Obstruction; Wheezing; Bronchodilators; Chest X-Ray
Nadira A Al-Baghl., et al. “Asthma: An Overview of Diagnosis and Management”. EC Microbiology 18.12 (2022): 69-76.
© 2022 Nadira A Al-Baghl., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by ECronicon is
licensed under a Creative Commons Attribution
4.0 International License
Based on a work at www.ecronicon.net